BIO-RAD LABORATORIES, INC. (BIO-B) Financial Forecast
United States · Health Care · USD (Millions) · Annual
Key financials
USD|Millions
ROE
10.84%
2025 (actual)
ROA
7.62%
2025 (actual)
Gross Margin
51.87%
2025 (actual)
Net Margin
29.42%
2025 (actual)
Total Assets
$10,576.50M
2025 (actual)
Net Income
$759.90M
2025 (actual)
Valuation
$8,307.55M
2026 (forecast)
Stock Price
$310.70
Historical & projected performance
USD|Millions
Reported figures and Equlion model projections for the next 5 years.
ROE
-13.2 pt
Company
Sector average (own scale)
ROA
-8.8 pt
Company
Gross Margin
-17.6 pt
Company
Sector average
Net Margin
-33.8 pt
Company
Total Assets
+46.6%
Company
Sector average
Net Income
-123.5%
Company
Valuation
-27.9%
Company
Sector average (own scale)
Stock Price
-27.9%
Company
Sector average (own scale)
Amounts in USD (millions); stock price per share. Values that are missing or fail Equlion's automated data-quality checks are shown as “-”. Stock price and valuation carry no data date: they are the Equlion model's estimate for 2026. Projections are model estimates, not investment advice.
Want the full financial forecast report for BIO-RAD LABORATORIES, INC.? It covers the balance sheet, income statement, cash flow and Equlion model projections.